Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS England’s Medicines Procurement and Supply Chain (MPSC) team seeks to procure a subscription-based information service providing comprehensive, real-time access to UK and EU patent data, proprietary Loss of Exclusivity (LoE) analysis, and forecasting for medicines, including small molecules, biologics, and clinical candidates. This resource will enable accurate identification of patent expiry opportunities, supporting strategic planning and delivery to maximise value for the NHS. Patent expiry is a critical driver of cost savings, typically reducing prices of equivalent medicines by 70–90% compared to originator products. The solution must include expert advisory support, litigation tracking, and timely updates on regulatory and market events, ensuring NHS England can adopt proactive, data-driven commercial strategies.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| IPD Analytics, LLC | Procurement ID: PNYT-9342-VMHX | £43,628 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Awarded To | Status |
|---|---|---|---|
| Lot 1 Apr 2026 – Mar 2027 | £45,000 £43,628 initial term | IPD Analytics, LLC | active |